Cancer Drug Parity Laws Lower Costs for Many, But Not For Everyone
News
Related Biotechnology, Pharmaceutical and Healthcare News
Forty-three states and Washington D.C. enacted so-called "parity
laws" since 2011.
Contributed Author:
UNC Lineberger Comprehensive
Cancer Center
Original Article: Cancer Drug Parity Laws Lower Costs for Many, But Not For Everyone
NEXT ARTICLE
More From BioPortfolio on "Cancer Drug Parity Laws Lower Costs for Many, But Not For Everyone"